150 related articles for article (PubMed ID: 26968559)
1. Cytokeratin 17 is highly sensitive in discriminating cutaneous lymphadenoma (a distinct trichoblastoma variant) from basal cell carcinoma.
Goyal A; Solus JF; Chan MP; Doyle LA; Schaffer A; Thakuria M; Horn TD; Duncan LM; Nazarian RM
J Cutan Pathol; 2016 May; 43(5):422-9. PubMed ID: 26968559
[TBL] [Abstract][Full Text] [Related]
2. BerEp4, cytokeratin 14, and cytokeratin 17 immunohistochemical staining aid in differentiation of basaloid squamous cell carcinoma from basal cell carcinoma with squamous metaplasia.
Linskey KR; Gimbel DC; Zukerberg LR; Duncan LM; Sadow PM; Nazarian RM
Arch Pathol Lab Med; 2013 Nov; 137(11):1591-8. PubMed ID: 24168496
[TBL] [Abstract][Full Text] [Related]
3. Use of Cytokeratin 17 in the Differentiation Between Desmoplastic Trichilemmoma and Cutaneous Basal Cell Carcinoma.
Chaudet KM; Stagner AM; Nazarian RM
Am J Dermatopathol; 2022 Dec; 44(12):886-890. PubMed ID: 36197047
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical comparison of cutaneous lymphadenoma, trichoblastoma, and basal cell carcinoma: support for classification of lymphadenoma as a variant of trichoblastoma.
McNiff JM; Eisen RN; Glusac EJ
J Cutan Pathol; 1999 Mar; 26(3):119-24. PubMed ID: 10235376
[TBL] [Abstract][Full Text] [Related]
5. CD10, TDAG51, CK20, AR, INSM1, and Nestin Expression in the Differential Diagnosis of Trichoblastoma and Basal Cell Carcinoma.
Leblebici C; Bambul Sığırcı B; Kelten Talu C; Koca SB; Huq GE
Int J Surg Pathol; 2019 Feb; 27(1):19-27. PubMed ID: 29938548
[TBL] [Abstract][Full Text] [Related]
6. Basal cell carcinoma: CD56 and cytokeratin 5/6 staining patterns in the differential diagnosis with Merkel cell carcinoma.
Panse G; McNiff JM; Ko CJ
J Cutan Pathol; 2017 Jun; 44(6):553-556. PubMed ID: 28403527
[TBL] [Abstract][Full Text] [Related]
7. Cytokeratin 17: an adjunctive marker of invasion in squamous neoplastic lesions of the anus.
Nazarian RM; Primiani A; Doyle LA; Linskey KR; Duncan LM; Odze RD; Zukerberg LR
Am J Surg Pathol; 2014 Jan; 38(1):78-85. PubMed ID: 24335642
[TBL] [Abstract][Full Text] [Related]
8. Anti-cytokeratin 20 staining of Merkel cells helps differentiate basaloid proliferations overlying dermatofibromas from basal cell carcinoma.
Mahmoodi M; Asad H; Salim S; Kantor G; Minimo C
J Cutan Pathol; 2005 Aug; 32(7):491-5. PubMed ID: 16008693
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of cytokeratin 15, TDAG51, cytokeratin 20 and androgen receptor in sclerosing adnexal neoplasms and variants of basal cell carcinoma.
Evangelista MT; North JP
J Cutan Pathol; 2015 Nov; 42(11):824-31. PubMed ID: 26016446
[TBL] [Abstract][Full Text] [Related]
10. Cytokeratin 20 expression in basaloid follicular hamartoma and infundibulocystic basal cell carcinoma.
Honarpisheh H; Glusac EJ; Ko CJ
J Cutan Pathol; 2014 Dec; 41(12):916-21. PubMed ID: 25353070
[TBL] [Abstract][Full Text] [Related]
11. Desmoplastic Trichoepithelioma: An Uncommon but Diagnostically Problematic Benign Adnexal Tumor.
Bartoš V
Acta Dermatovenerol Croat; 2019 Dec; 27(4):282-284. PubMed ID: 31969246
[TBL] [Abstract][Full Text] [Related]
12. p40 in Conjunction With CK20 and E-Cadherin Distinguishes Primary Adnexal Neoplasms of the Skin.
Andruszkow JH; Oll M; Förster S; Knüchel R; Jäkel J
Appl Immunohistochem Mol Morphol; 2016 Jul; 24(6):414-21. PubMed ID: 26180934
[TBL] [Abstract][Full Text] [Related]
13. PHLDA1, a follicular stem cell marker, differentiates clear-cell/granular-cell trichoblastoma and clear-cell/granular cell basal cell carcinoma: a case-control study, with first description of granular-cell trichoblastoma.
Battistella M; Peltre B; Cribier B
Am J Dermatopathol; 2014 Aug; 36(8):643-50. PubMed ID: 23719479
[TBL] [Abstract][Full Text] [Related]
14. Cytokeratin expression in trichoblastic fibroma (small nodular type trichoblastoma), trichoepithelioma and basal cell carcinoma.
Yamamoto O; Asahi M
Br J Dermatol; 1999 Jan; 140(1):8-16. PubMed ID: 10215762
[TBL] [Abstract][Full Text] [Related]
15. Follicular induction and CK20+ Merkel cells overlying cutaneous focal mucinosis.
Chairatchaneeboon M; Elenitsas R; Nguyen JV
J Cutan Pathol; 2019 Mar; 46(3):195-198. PubMed ID: 30552701
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of cytokeratin 15, cytokeratin 19, follistatin, and Bmi-1 in basal cell carcinoma.
Kim HC; Sohng SH; Shin DH; Choi JS; Bae YK
Int J Dermatol; 2016 Jan; 55(1):36-44. PubMed ID: 26739632
[TBL] [Abstract][Full Text] [Related]
17. Trichoblastoma and basal cell carcinoma are neoplasms with follicular differentiation sharing the same profile of cytokeratin intermediate filaments.
Schirren CG; Rütten A; Kaudewitz P; Diaz C; McClain S; Burgdorf WH
Am J Dermatopathol; 1997 Aug; 19(4):341-50. PubMed ID: 9261468
[TBL] [Abstract][Full Text] [Related]
18. Merkel cell-poor trichoblastoma with basal cell carcinoma-like foci.
Misago N; Satoh T; Miura Y; Nagase K; Narisawa Y
Am J Dermatopathol; 2007 Jun; 29(3):249-55. PubMed ID: 17519622
[TBL] [Abstract][Full Text] [Related]
19. Cervical Adenoid Basal Carcinoma: Clinicopathologic Features of 9 Cases With Reference to CK17 and Ki-67 Expression.
Liang Y; Lü B; Zhou C
J Low Genit Tract Dis; 2019 Jan; 23(1):77-81. PubMed ID: 30106815
[TBL] [Abstract][Full Text] [Related]
20. Basaloid tumors arising from seborrheic keratosis: Malignant basal cell carcinoma or benign basaloid follicular hamartomatous proliferation?
Flordelis JO; Shen YC; Wu YH
J Cutan Pathol; 2020 Mar; 47(3):207-218. PubMed ID: 31682281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
